New technology offer: highly selective, orally bioavailable FAP inhibitors
Please see the following link/ https://medialibrary.uantwerpen.be/oldcontent/container39124/files/TTO-15-E-1706-FAP_Inhibitors.pdf
Technology offer: New lead compounds for dry eye disease and validated dry eye disease rat model
Please see the following link: https://medialibrary.uantwerpen.be/oldcontent/container39124/files/TTO-14-E-1706-DryEyesDisease.pdf
Technology offer: Validated gastrointestinal model of visceral pain for preclinical drug testing
Please see the following link: https://medialibrary.uantwerpen.be/oldcontent/container39124/files/TTO-18-E-1707-GastrointestinalModel.pdf
Technology offer: New serine protease inhibitors to treat visceral pain for preclinical drug testing
Please see the following link: https://medialibrary.uantwerpen.be/oldcontent/container39124/files/TTO-19-E-1707-serine%20protease%20inhibitors.pdf